NCT00014742View on ClinicalTrials.gov

Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 2004

Conditions
Dupuytren's Contracture
Interventions
DRUG

collagenase

All Listed Sponsors
lead

State University of New York

OTHER

NCT00014742 - Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease | Biotech Hunter | Biotech Hunter